House Energy and Commerce Committee Chairman Greg Walden (R-OR) last night unveiled a bill to extend funding for the Children’s Health Insurance Program through fiscal year 2022, modify reductions in Medicaid disproportionate share payments to hospitals and provide $1 billion in Medicaid funding to Puerto Rico. Under the Helping Ensure Access for Little ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable (HEALTHY KIDS) Act, CHIP’s federal matching rate would remain at 23% through FY 2019, change to 11.5% for FY 2020, and return to a traditional CHIP matching rate for FYs 2021 and 2022. These provisions are the same as a bill introduced last month in the Senate Finance Committee. In addition, the House bill would delay the Medicaid DSH cuts for FY 2018, but add two more years of cuts for 2026 and 2027. Offsets in the bill include changes to Medicaid third party liability and treatment of lottery winnings and other lump-sum income for purposes of income eligibility under Medicaid, as well as adjustments to Medicare Part B and Part D premium subsidies for higher-income individuals. The House Energy and Commerce Committee and Senate Finance Committee both plan to mark up their respective bills tomorrow. While CHIP is authorized through Oct. 1, 2019, legislative action is needed to reauthorize funding, which expired Sept. 30.

Related News Articles

Headline
The AHA collaborated with LCMC Health in New Orleans to spotlight innovative efforts that extend care beyond hospital walls. LCMC Health supports families…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2026 health coverage via the Health Insurance…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…